Literature DB >> 23037151

Carbohydrate mimetic peptides as research reagent and therapeutic.

Michiko N Fukuda1, Shingo Hatakeyama, Kazuhiro Sugihara.   

Abstract

Although numerous carbohydrates play significant roles in mammalian cells, development of carbohydrate-based reagents and therapeutics are hampered by the technical difficulty of chemically synthesizing complex carbohydrate structures. Use of carbohydrate mimetic peptides circumvents this difficulty, as short peptide can be easily synthesized and modified. We as well as others identified carbohydrate mimetic peptides by screening peptide displaying phage library using anti-carbohydrate antibodies and lectins. This review introduces our experiences with I-peptide that was used for identification of new carbohydrate binding receptor expressed in the lung endothelial cells, and those with IF7 peptide that can be used as a therapeutic against malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23037151     DOI: 10.1248/bpb.b12-00395

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  1 in total

1.  Retro-inverso carbohydrate mimetic peptides with annexin1-binding selectivity, are stable in vivo, and target tumor vasculature.

Authors:  Xinyi Chen; Zhuoyang Fan; Yanzuo Chen; Xiaoling Fang; Xianyi Sha
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.